GlassScriptPhysician profile
Chadi G Haddad
NPI 1750371621
$2,947.43
in general payments reported to CMS, 2019-2025
27 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $207 · 2021: $691 · 2022: $789 · 2023: $198 · 2024: $244 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $454.31 | 2021-2022 | |
| Abbvie INC. | $446.76 | 2019-2025 | |
| Gynesonics, INC. | $257.26 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $231.71 | 2020-2024 | Acessa Provu System |
| Coopersurgical, INC. | $222.07 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Aspira Women'S Health INC | $176.23 | 2021-2025 | Ova1 |
| Sumitomo Pharma America, INC. | $155.09 | 2024-2025 | Myfembree, Gemtesa |
| Ethicon US, LLC | $149.70 | 2020-2025 | Enseal, Vistaseal, Dermabond |
| Lsi Solutions INC | $123.40 | 2019 | |
| Asensus Surgical, INC. | $120.83 | 2019 | |
| Minerva Surgical, INC | $119.00 | 2019 | |
| Organon LLC | $91.54 | 2021-2025 | Nexplanon |
| Baxter Healthcare | $75.02 | 2022-2025 | Perclot |
| Pfizer INC. | $52.57 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.70 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $43.88 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $26.50 | 2023 | Exparel |
| Amag Pharmaceuticals, INC. | $19.82 | 2019 | |
| Novo Nordisk INC | $19.29 | 2024 | Wegovy |
| Sage Therapeutics, LLC | $17.68 | 2022 | |
| Meditrina | $17.30 | 2025 | |
| Evofem Biosciences, INC. | $16.90 | 2021 | |
| Exact Sciences Corporation | $15.42 | 2025 | Cologuard Collection Kit |
| Coloplast Corp | $13.91 | 2019 | |
| Daiichi Sankyo INC. | $13.26 | 2022 | |
| Shield Therapeutics INC | $11.88 | 2022 | |
| Boston Scientific Corporation | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadi Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.